A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris (NCT07532603)
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Lichen Planopilaris
🩺 Plain-English Summary (8th-Grade Level)
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Who can join: Review the eligibility criteria below.
Location: Clinical Trial Site — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (61 Sites)
Showing the first 25 of 61 sites.
- Clinical Trial Site — Birmingham, Alabama
- Clinical Trial Site — Phoenix, Arizona
- Clinical Trial Site — Scottsdale, Arizona
- Clinical Trial Site — Irvine, California
- Clinical Trial Site — Oakland, California
- Clinical Trial Site — Sacramento, California
- Clinical Trial Site — San Francisco, California
- Clinical Trial Site — Denver, Colorado
- Clinical Trial Site — Farmington, Connecticut
- Clinical Trial Site — New Haven, Connecticut
- Clinical Trial Site — Miami, Florida
- Clinical Trial Site — Chicago, Illinois
- Clinical Trial Site — Skokie, Illinois
- Clinical Trial Site — Clarksville, Indiana
- Clinical Trial Site — Indianapolis, Indiana
- Clinical Trial Site — Leawood, Kansas
- Clinical Trial Site — Louisville, Kentucky
- Clinical Trial Site — Boston, Massachusetts
- Clinical Trial Site — Burlington, Massachusetts
- Clinical Trial Site — Ann Arbor, Michigan
- Clinical Trial Site — Ann Arbor, Michigan
- Clinical Trial Site — Medina, Minnesota
- Clinical Trial Site — Minneapolis, Minnesota
- Clinical Trial Site — Kansas City, Missouri
- Clinical Trial Site — Lee's Summit, Missouri
📞 Contact the Study Coordinator
Phone: (212) 634-9743
Email: clinicaltrials@priovant.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Lichen Planopilaris clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.